← Open Payments lookup

KASEY DUNN: Open Payments

NPI 1588286389 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$864 in 43 payments from 22 companies in 2025. Trend: 2023 $477 · 2024 $805 · 2025 $864

Food & beverage: $864
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$141
Novartis Pharmaceuticals Corporation4$74
Celgene Corporation3$66
Janssen Biotech, Inc.3$64
E.R. Squibb & Sons, L.L.C.3$56
PFIZER INC.3$54
Daiichi Sankyo Inc.2$44
Stemline Therapeutics Inc.2$38
Takeda Pharmaceuticals U.S.A., Inc.1$37
GlaxoSmithKline, LLC.2$35

Products named: REBLOZYL, OPDIVO, IBRANCE, LYNPARZA, ENHERTU, Orserdu, NINLARO, SCEMBLIX.

Industry payments across LA — which companies pay providers there.